论文信息 - The polycomb group protein BMI-1 inhibitor PTC-209 is a potent anti-myeloma agent alone or in combination with epigenetic inhibitors targeting EZH2 and the BET bromodomains - 字舞流文

The polycomb group protein BMI-1 inhibitor PTC-209 is a potent anti-myeloma agent alone or in combination with epigenetic inhibitors targeting EZH2 and the BET bromodomains

H. Nahi | C. Heckman | K. Nilsson | F. Öberg | Jian Jin | Anqi Ma | A. Österborg | M. M. Majumder | H. Jernberg-Wiklund | Alba Atienza Párraga | Mohammad Alzrigat | Antonia Kalushkova | A. Kalushkova